Skip to main content
Equibles

Jill Broadfoot

CFO

aTYR PHARMA INC (ATYR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jill Broadfoot

Jill Broadfoot is recorded as CFO at aTYR PHARMA INC (ATYR). The proxy statement of aTYR PHARMA INC reports total compensation of $1,309,913 for Jill Broadfoot in fiscal 2025, including a base salary of $471,790. Disclosed compensation is on record for 8 fiscal years. Jill Broadfoot has spoken on 14 earnings calls and 1 other investor event across 1 company, most recently for aTYR PHARMA INC on September 15, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at aTYR PHARMA INC

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 aTYR PHARMA INC (ATYR) $471,790 $1,309,913
2024 aTYR PHARMA INC (ATYR) $428,899 $746,163
2023 aTYR PHARMA INC (ATYR) $414,395 $677,837
2022 aTYR PHARMA INC (ATYR) $414,395 $913,493
2021 aTYR PHARMA INC (ATYR) $376,723 $917,443
2020 aTYR PHARMA INC (ATYR) $365,750 $698,780
2019 aTYR PHARMA INC (ATYR) $350,000 $454,624
2018 aTYR PHARMA INC (ATYR) $148,526 $334,123

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 3 earlier activities